Use of the anti-IgE medication omalizumab in combination with oral immunotherapy led 83 percent of patients with multiple food allergies… Read more »
Use of the anti-IgE medication omalizumab in combination with oral immunotherapy led 83 percent of patients with multiple food allergies… Read more »